strong items around EPS Adjusted to performance by including continued X basis. continued by offset the negatively Pharmacy was on lower The lower Retail gross wholesale. International a of margin. impacted management bonus improved year-on-year prior from constant currency a Pharmacy Stefano good $X.XX, Pharmaceutical Retail were saw by USA, comparison In and adverse than and we and X.X% strong morning. be year-on-year you, impacted sales Thank was comp challenging percentage impact. retail cost year U.K points market
Our for or fiscal better Transformational a constant adjusted minus per million, is strong we was with of Cost expect year. prior we flat XXXX. maintaining much basis our than million Program cost $XXX annual on finally, track. currency X%. free Management with the range earnings of And by of of Cash savings $X.X quarter share flow year $XXX plus are generation on And 'XX to in guidance excess a cash very very achieve billion in
XX Looking as but full-year we guidance. business impact EPS and quarter total, impacts. in and of noise timing see second result core year-on-year with improved trends cycle in XX% both some bonus on the In expected no fiscal payments forward, around in we year headwind the these were these have reimbursement budgeted an of items through however of
Let's results. look now detail more the in on
quarter X.X%. income lower were X.X%. X.X% currency currency operating First basis, basis, decline constant gross in a margin declined were the including difficult a was EPS $X.XX a up Adjusted constant sales up on Adjusted currency XX.X% sales of currency reflecting of UK a market. headwind US X% constant and on a
from favorable X additional we from a percentage program X.X tax Our as of number growth points an contributed of percentage points discrete and benefited a rate came items. share repurchase
the funding. the year year lapping included Management items mark-to-market the X transaction Transformational points, and reflected impact, the XX.X% on also adjustments of of supplier Aid result to bonus year relating $X.XX Program. Cost adverse and The implementation EPS declined over prior and including GAAP percentage to Rite costs
X.X% sales sales. Pharmacy pharmacy, retail in growth USA. in by offset increased lower Now to the partially Retail move quarter X.X% let's with
XX.X% X.X XX versus was of Adjusted and our gross decreased gross year. improvement points Note the spend that includes and the sales lower negative pharmacy an program. prior to due due sales, retail of profit, impact declined adjusted of in growth the store optimization profit X.X% basis to X.X% SG&A quarter points percentage
shows were and impact. bonus strong Transformational in more impact Adjusted against offsetting our Program operating execution incremental income savings, Cost year-on-year clearly of the XX.X% than the of declined our investments with The SG&A, decline not enough Management inflation in In points for earlier. and savings these percentage the mentioned gross in adverse operating items profit over decline total I X decline items SG&A of accounted to the adverse offset the income. the
grow look X.X%. Central at increased pharmacy. were Total growth. script pharmacy Now more sales year, let's X.X% nicely Comp and and up prior scripts in continue versus sales up detail pharmacy reflecting comp brand X.X% versus volume X.X% prior grew inflation continued year. specialty to sales
weeks. down XX basis we improved quarter versus the XX.X%, store Market impact weaker was this seen prior have our was for than program. While expected, share including points optimization the in year growth recent from
and gross the pressure. script was adjusted offset profit by of reimbursement procurement growth impact as mid savings more than decreased single-digit,
and Turning retail next store X.X% retail sales by declined impacted an optimization. Total to US improving to retail our declined business. Comp trend. quarter, show the sales in continued X.X%
e-cigarettes, tobacco Excluding comp and sales were X.X%. up
the As sale we e-cigarettes. of you know exiting are
beauty EPS health .We growth not significant have bigger quarter, in X.X%. year around continue comps our categories quarter did it with and full impact we saw anticipate this a this from on a will impact and to solid up a of While have comp next up $X.XX impact X.X% onwards. wellness core the And
of the programs, funding. tailwind low higher prior the timing and declined lower shrink category in single shrink impact year. Adjusted supplier points however, and slightly prior funding timing optimization sales, margins excluding a flu. digits XX declined around estimate margin including of profit basis cold, due store year of with were higher gross Retail supplier from the gross to cough, underlying We line adjusted
the currency constant from Turning reflecting mainly levels higher X.X% usual, next NHS in due Boots increased Sales to pharmacy partly Retail Pharmacy increased International relatively reimbursement [indiscernible] sales and the and numbers. UK X.X% UK volume. and lower to offset script as comp by sales services Chile. quarter decreased
Street sales Boots the X.X%, UK retail High comp to very continued as challenging. declined be UK
adjusted held and income and we percentage impact XX year-on-year was down include lower an impact to points mainly share XX.X% from overall adverse bonus due UK of higher volume sales technology operating investments. However, results The the retail margin. market
also and in X.X% which Pharmaceutical division, in division constant the performance sales The sales growth, markets contributing Wholesale this with have I've the overall by to now impact change quarter lapped which customer strong The the currency. the contract, Turning we up now another Wholesale of Pharmaceutical our I'll X.X% to led emerging UK. delivered UK help mentioned before, contract the change. discuss
Wholesale increased in drug the EPS reflecting efficiency. sustainable from Adjusted scale to profit operating contribution accelerate to improving a Bergen. Europe income by market JV the venture X.X% drive growth aims with leveraging strong performance pharmaceutical joint our accretive we higher revenue to on Mid-term expect be profitable largest growth. and strategic and These Pharmaceutical in McKesson Amerisource
million million $XXX strong flow. versus $XXX flow year. cash on at cash Operating up to million, $X.X next was prior Free flow up billion, $XXX year. cash was prior Turning
initiatives key working Our are capital track. on
the extend of to have period. system, we We strong started industry we to fuel are pipeline removing and excess inventory cash a to a multiyear payment our levels. generation initiatives leading have Ad over flow terms from
have target. and Cost annual this excess cost a by pipeline to much now confidence now gives robust our billion October, our Transformational in fiscal turn savings our exceed momentum, level very a we higher We Let's raised that to In of gaining initiatives Program. $X.X Management target can are savings XXXX. of we billion us $X.X
to and Importantly, innovative the these create models. needed savings will fund allow business us to investments new
resale. some on you activities to spend, our in On we is we program. our opportunities our interesting. procurement the see give Let smart not activities for And energy me in management detail are up efficiency management now program quarter. accelerating goods, energy The ramp
process undertaken leading is the Boots organization, of saves operating invest business example is consumers. improves all perfect money friendly U model. with end-to-end aim we're experience and grow. the of lighting a major This covering effective in smart processes to an to On transforming LED we ultimately a operate, to for environmentally how UK and save lean review store
implementation the XXX of we divisional XXX actively UK the closures. completed and planning the reductions business services in We are On implemented second Thailand. and and of have Chile XXX global of the wave closures Boots cost store Mexico, of optimization have headquarter Walgreens we now XX
to XX new now US stores with small in test we're store We continue results. operating formats the and encouraging
have vendor progressing well. operating model is a optimization our we and implementation work IT, On started of new
On in work recently pharmacy digitalization system. pharmacy the we critical Consulting selected reinventing Services prescription our the example, and we For prioritized partner journey. new operating mass have Tata investments our to personalization accelerate on as
Now, over to I'll hand Alex.